Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability.
about
Association of retinal and macular damage with brain atrophy in multiple sclerosisEarly B-cell Factor gene association with multiple sclerosis in the Spanish population.Neurodegeneration in multiple sclerosis: novel treatment strategiesNew and emerging disease modifying therapies for multiple sclerosisReview of interferon beta-1b in the treatment of early and relapsing multiple sclerosisCognitive impairment in probable multiple sclerosisTherapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis.Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopyImaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple SclerosisOptimizing the initial choice and timing of therapy in relapsing-remitting multiple sclerosisViruses and neurodegenerationThe impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trialsAdaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage.Clinical proton MR spectroscopy in central nervous system disordersTwelve-year monitoring of a patient with megalencephalic leukoencephalopathy with subcortical cysts.MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment.Multicentre proton magnetic resonance spectroscopy imaging of primary progressive multiple sclerosis.Imaging of multiple sclerosis: role in neurotherapeutics.Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.Magnetic resonance spectroscopy in the monitoring of multiple sclerosis.Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.MRI in multiple sclerosis: what's inside the toolbox?N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: a quantitative pixelwise analysisTreatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode.N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry.Neuroprotective effects of gypenosides in experimental autoimmune optic neuritis.The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis.Global N-acetylaspartate declines even in benign multiple sclerosisOnce-daily glatiramer acetate decreases magnetic resonance imaging disease activity in Japanese patients with relapsing-remitting multiple sclerosis.Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosisAerobic fitness is associated with gray matter volume and white matter integrity in multiple sclerosisMyelin loss does not lead to axonal degeneration in a long-lived model of chronic demyelinationPathogenic implications of iron accumulation in multiple sclerosis.The photopic negative response of the flash electroretinogram in multiple sclerosis.Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-A unifying hypothesis.Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis.Evolving expectations around early management of multiple sclerosis.Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration.Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.
P2860
Q21135504-DB406716-31D4-4A1E-ACBE-9032E494D2E4Q21261385-70B298AC-CECF-4961-B6A4-0E3623A0BD32Q22241472-C6C9F099-B786-457C-A433-ED4131F39AEDQ22242305-62785E5F-0AA1-4E4C-A435-8171CB28FC19Q24652353-D0720EC1-892A-4DD4-B94C-F31A55CF48DFQ24672050-3AFB2938-4C70-4D47-A1E8-E965DF365ACCQ24681228-BF453DB5-F673-4791-A0E1-35DF3A3235CBQ24800569-486D9EB3-4885-439D-A034-CE0161BD1C64Q26744629-E8725A0F-BD42-4776-BFAF-3CD3FADCB963Q26777686-B9466570-DF49-48AC-BAA7-BCA588DFC75CQ26991740-D65B6207-4746-400C-918E-9EDBE7750C02Q28741521-08C2A58E-B01F-48D1-835A-CF12C89C0A86Q30679381-5A5040F9-6D55-4532-9DD4-EE9FC80C7062Q30764446-BB47A299-3FBF-43E8-B5E5-093F1BC43453Q30768212-0157CDCA-161A-414E-A2D3-3F26E34437C8Q30798662-3C937136-5B4E-4E6F-AEFF-E5DAF3AC3D5FQ30940050-0359EF1C-C758-486D-AF90-E4311FD37779Q30989935-55C6AAAC-803D-4C02-AE01-07370D6FD459Q31027249-F33442FB-F62C-4268-AE7A-29519AD051D5Q31027957-0201DC45-1164-4D74-883B-52C498B95CBFQ31104509-8EB4F376-4477-4153-9577-075198DB0189Q31132442-F93663E1-CEC8-4DA8-9AEF-E14FCAF76B92Q33271816-C0D73F64-0F84-474F-89F3-46FD5421B17DQ33414966-E4B8283A-CDB0-4514-B8DB-19974D0EF742Q33500910-78363D05-3C90-40CF-BE14-1E2D0BEB3CF2Q33556095-C6B617C2-81A1-41DF-A75B-8285913372E8Q33607732-846F337E-7A64-4614-B212-8AFDEE5AE291Q33698702-1254900F-BD49-4DCA-BBB0-BA303CF850C8Q33725131-22E7842D-9D83-4861-B17E-57EFE912D83DQ33835877-8996EA10-5E66-4171-B197-3A6EE67FB568Q33869433-219EAD2E-0D23-4BFD-B5FC-1C618238DB3CQ33907522-9134F93C-6C62-47CA-91CC-D8075E600512Q34027469-1CCAACE3-B206-475F-A667-CEA2EBB37422Q34049616-097F48B3-0D8C-4C5F-AE23-8500588FEBE7Q34138418-2A4092AB-2148-4D3D-BDD0-82AACB39E179Q34213029-176DC3D6-3941-48C9-ACE0-A7318F89F9CAQ34221185-DD2F23E4-09D6-4931-B84E-EC157C203597Q34409412-C3FBE519-BDC5-47A4-A60A-0E7D6EE5D723Q34463760-47D982B5-356B-4935-85F5-848B62DF7311Q34552395-9BC26A07-190D-482D-AD2D-5820C9489A6A
P2860
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Evidence of axonal damage in t ...... d its relevance to disability.
@ast
Evidence of axonal damage in t ...... d its relevance to disability.
@en
type
label
Evidence of axonal damage in t ...... d its relevance to disability.
@ast
Evidence of axonal damage in t ...... d its relevance to disability.
@en
prefLabel
Evidence of axonal damage in t ...... d its relevance to disability.
@ast
Evidence of axonal damage in t ...... d its relevance to disability.
@en
P2093
P356
P1433
P1476
Evidence of axonal damage in t ...... d its relevance to disability.
@en
P2093
Arnaoutelis R
Francis GS
Matthews PM
Narayanan S
Tartaglia MC
P356
10.1001/ARCHNEUR.58.1.65
P577
2001-01-01T00:00:00Z